Diligence memo · auto-generated · as of July 2, 2026

Shine Medical Technologies, Inc.

Shine Medical Technologies, Inc. looks fair against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Shine Medical Technologies, Inc. operates in Healthtech, based in JANESVILLE.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Shine Medical Technologies, Inc. has raised $84M in disclosed capital across 5 recorded rounds, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).

Largest single filing: $29M on 2013-10-11.

Most recent recorded round closed around 2019-04-26.

Valuation (modeled)modeled

Provath models Shine Medical Technologies, Inc. at approximately $448M (range $42M–$1.7B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 1.00× the median modeled value of Series B Healthtech companies in 2019–2021 (56 peers) — value vs value, same stage and era. Within the normal band (100% of peer median) for its niche.

Financing rhythm & timingmixed

Historic cadence: a new round about every 11 months.

Last raise 7.2 yr ago; this sector typically re-raises about every 14 months.

Silent for over 3× the sector's normal cadence.

The last round stepped up 1.0× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 95% of Healthtech peers (2138 compared).

Modeled value ranks above 93% of those peers.

Closest niche peers: Solera Health, Inc., Icebreaker Health, Inc., Buoy Health, Inc., Stroma Medical Corp, HealthJoy, Inc..

Peoplefiled

23 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.